ArticleJournal of experimental & clinical cancer research : CR2015

Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.

Miroslava Matuskova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.